Travere’s Filspari becomes the first FDA-approved medication for FSGS

April 15, 2026

ADC Therapeutics terminates Zynlonta study after FDA puts a hold

July 25, 2023

The Rise of Value-Based Pricing in Life Sciences

April 10, 2026

Must Read

Top 10 Data Governance Priorities for Life Sciences Leaders

September 3, 2026

Agentic AI in Life Sciences

September 3, 2026

Novartis Reports Positive Phase 3 Results for Rhapsido in Relapsing Multiple Sclerosis

September 2, 2026

About Us

Life Sciences Voice is the leading resource for life sciences executives to get crucial insights, explore the latest innovations, and learn about industry trends. Life Sciences Voice provides the community with thought-provoking commentary in multiple formats covering a range of issues from drug discovery to commercial success.

Novo Launches Late-Stage Trial of Lower-Dose Wegovy Pill for Weight Management

Oregon Study Finds Triple-Drug Regimen Kept Infant Macaques HIV-Free for One Year

Summit and Akeso Report Updated HARMONi Survival Data for Ivonescimab in Western NSCLC Patients

ARPA-H Awards Up to $160 Million for Personalized Genetic Medicine Development

Novartis Reports Positive Phase 3 Results for Rhapsido in Relapsing Multiple Sclerosis

Ambros and Werewolf Merge as Neridronate Advances in Phase 3 Trial for CRPS-1

Another late-stage victory for Tezspire is achieved by AstraZeneca and Amgen, this time in esophagitis

Despite a mid-stage failure, Bausch + Lomb moves a medication for dry eye condition to Phase 3

Roche Licenses Hanmi’s HM17321 Obesity Candidate in Deal Worth Up to $2.3 Billion

Leo Pharma Pens Mega Deal to Buy Tanabe’s Skin Disease Drug

PTC Therapeutics Acquires ST-920 Fabry Disease Gene Therapy Program From Sangamo

Suki Launches AI Dictation Tool Integrated With Epic and Meditech EHRs

Claryx Appears From Stealth to Deal with the $45B Hospital-Acquired Infections Issue

J&J’s OTTAV Robotic Surgical System has received FDA market authorization in the U.S.

Alnylam Inks $2B Agreement With Inceptive to Change sIRNA Design With AI Leader

Top 10 Data Governance Priorities for Life Sciences Leaders

Agentic AI in Life Sciences

Why AI Agents Will Become Every Pharmaceutical Employee’s Copilot

How Digital Twins Are Transforming Drug Development

Editorial Team

Sarclisa Escena Wins FDA Approval for Subcutaneous Use in Multiple Myeloma

Editor Picks

Travere’s Filspari becomes the first FDA-approved medication for FSGS

ADC Therapeutics terminates Zynlonta study after FDA puts a hold

The Rise of Value-Based Pricing in Life Sciences

Must Read

Top 10 Data Governance Priorities for Life Sciences Leaders

Agentic AI in Life Sciences

Novartis Reports Positive Phase 3 Results for Rhapsido in Relapsing Multiple Sclerosis

Hot Topics

About Us

Follow Us